Partnership for Safe Medicines petitions FDA to block compounding of six peptides
The group targets BPC-157, TB-500, KPV, MOTS-c, emideltide and semax, and says it bought unapproved peptide vials from telehealth sellers to show the risk.
Recap by typeshit. Full story at Partnership for Safe Medicines.